{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T16:48:38Z","timestamp":1788281318123,"version":"build-2803163510"},"reference-count":7,"publisher":"Springer Science and Business Media LLC","issue":"3","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dermatol Ther (Heidelb)"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1007\/s13555-015-0082-5","type":"journal-article","created":{"date-parts":[[2015,8,24]],"date-time":"2015-08-24T03:46:08Z","timestamp":1440387968000},"page":"201-205","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["5-Fluorouracil \u201cChemowraps\u201d in the Treatment of Multiple Actinic Keratoses: A Norwich Experience"],"prefix":"10.1007","volume":"5","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9940-7788","authenticated-orcid":false,"given":"Peter K. C.","family":"Goon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Clegg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian S. W.","family":"Yong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ava S. W.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin Y. C.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nick J.","family":"Levell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eunice K. H.","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syed N.","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,8,25]]},"reference":[{"key":"82_CR1","doi-asserted-by":"crossref","unstructured":"Pomerantz H, Hogan D, Eilers D, et al. Long-term efficacy of topical fluorouracil cream, 5%, for treating actinic keratosis: a randomized clinical trial. JAMA Dermatol. 2015. doi: 10.1001\/jamadermatol.2015.0502 .","DOI":"10.1001\/jamadermatol.2015.0502"},{"issue":"8","key":"82_CR2","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1046\/j.1524-4725.2000.99197.x","volume":"26","author":"SE Chiarello","year":"2000","unstructured":"Chiarello SE. Cryopeeling (extensive cryosurgery) for treatment of actinic keratoses: an update and comparison. Dermatol Surg. 2000;26(8):728\u201332.","journal-title":"Dermatol Surg"},{"issue":"7","key":"82_CR3","first-page":"685","volume":"7","author":"M Mann","year":"2008","unstructured":"Mann M, Berk DR, Petersen J. Chemowraps as an adjuvant to surgery for patients with diffuse squamous cell carcinoma of the extremities. J Drugs Dermatol. 2008;7(7):685\u20138.","journal-title":"J Drugs Dermatol"},{"issue":"4","key":"82_CR4","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1111\/ajd.12055","volume":"54","author":"B Tallon","year":"2013","unstructured":"Tallon B, Turnbull N. 5% fluorouracil chemowraps in the management of widespread lower leg solar keratoses and squamous cell carcinoma. Australas J Dermatol. 2013;54(4):313\u20136.","journal-title":"Australas J Dermatol"},{"issue":"8","key":"82_CR5","first-page":"527","volume":"2","author":"A Lee","year":"2004","unstructured":"Lee A, Ezzeldin H, Fourie J, Diasio R. Dihydropyrimidine dehydrogenase deficiency: impact of pharmacogenetics on 5-fluorouracil therapy. Clin Adv Hematol Oncol. 2004;2(8):527\u201332.","journal-title":"Clin Adv Hematol Oncol."},{"issue":"9","key":"82_CR6","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.2217\/pgs.11.72","volume":"12","author":"U Amstutz","year":"2011","unstructured":"Amstutz U, Froehlich TK, Largiader CR. Dihydropyrimidine dehydrogenase gene as a major predictor of severe 5-fluorouracil toxicity. Pharmacogenomics. 2011;12(9):1321\u201336.","journal-title":"Pharmacogenomics."},{"issue":"Suppl 2","key":"82_CR7","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/j.1365-2133.2007.08271.x","volume":"157","author":"N Krawtchenko","year":"2007","unstructured":"Krawtchenko N, Roewert-Huber J, Ulrich M, Mann I, Sterry W, Stockfleth E. A randomised study of topical 5% imiquimod vs. topical 5-fluorouracil vs. cryosurgery in immunocompetent patients with actinic keratoses: a comparison of clinical and histological outcomes including 1-year follow-up. Br J Dermatol. 2007;157(Suppl 2):34\u201340.","journal-title":"Br J Dermatol"}],"container-title":["Dermatology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13555-015-0082-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,23]],"date-time":"2017-06-23T14:09:47Z","timestamp":1498226987000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13555-015-0082-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8,25]]},"references-count":7,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,9]]}},"alternative-id":["82"],"URL":"https:\/\/doi.org\/10.1007\/s13555-015-0082-5","relation":{},"ISSN":["2193-8210","2190-9172"],"issn-type":[{"value":"2193-8210","type":"print"},{"value":"2190-9172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,8,25]]}}}